Lightnews — Scholar-powered news

Armando Andres Roca Suarez

@andresroca.bsky.social

54 followers 160 following 3 posts

Virologist seeking to understand the complexities of liver disease by day and of brazilian jiu-jitsu by night. @ihuhepatolyon.bsky.social #Liversky #Hepsky

Posts Media Videos Starter Packs

Pinned

Armando Andres Roca Suarez @andresroca.bsky.social · Dec 3

Big thanks to the members of the @ihuhepatolyon.bsky.social, IP-cure-B 🇪🇺 and Gut for the opportunity to share our work. Barbara Testoni, Fabien Zoulim, Marie-Laure Plissonnier. #HBV #Kupffer #Liver
youtu.be/rhxBiquxHfU?...

TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV

YouTube video by Gastroenterology at BMJ

youtu.be

1 6

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · 25d

⏳ Only 2 weeks left to submit abstracts for #HEP-DART 2025!
Deadline: September 29, 2025

Join leading researchers and clinicians in 🌎 Honolulu, Hawaii, and share your latest work in #hepatitis research, treatment, and global health.

👉 informedhorizonseducation.com/abstracts-he...

1 2

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · Sep 13

Thank you team! You did an amazing work at presenting your data and we had a lot of fun!!! #HBV2025 @anrs-mie.bsky.social @ihuhepatolyon.bsky.social

2 5

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · Sep 8

Backstage from the #HBV2025 international meeting. we’re getting ready to welcome you all in Berlin! @anrs-mie.bsky.social @ihuhepatolyon.bsky.social

2 2

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Sep 2

🎓 [OFFRE DE POST-DOC – 24 mois]
📍 Domaine : Santé publique / Épidémiologie
📅 Candidatures jusqu’au 17 octobre 2025

🎓 Profil recherché :
- Doctorat en santé publique, épidémiologie ou discipline connexe
- Solides compétences en analyse de données

👉 Plus d'informations dans la fiche de poste

1 1

Reposted by Armando Andres Roca Suarez

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · Aug 19

FDA approves semaglutide for adults with metabolic-associated steatohepatitis with moderate-to-advanced fibrosis

www.fda.gov/drugs/news-e...

#LiverSky #MedSky

FDA Approves Treatment for Serious Liver Disease Known as ‘MASH’

Action Will Provide New Therapy for Growing Public Health Issue

www.fda.gov

3 3

Armando Andres Roca Suarez @andresroca.bsky.social · Jul 31

We look forward to receiving your contributions to the special issue "Cellular Immune Response to Hepatitis Viruses".
Deadline : 31 January 2026
#Hepsky #Liversky #Medsky

www.mdpi.com/journal/viru...

www.mdpi.com

1 1

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Jul 28

🌍 Today is #WorldHepatitisDay 2025!

〽️ At IHU Everest, we are committed to raising #awareness and support the global campaign: “Let’s break it down.” www.worldhepatitisday.org/take-action/

🤝 Let’s unite around one powerful message:
Take action. Get tested. End the stigma.

#EndStigma #HealthForAll

1 2

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Jul 24

www.thelancet.com/journals/lan...

#HBV #Medsky #Hepsky #Liversky

Scientific and medical evidence informing expansion of hepatitis B treatment guidelines

Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) replication, normalise liver enzymes, and slow disease progression with excellent ...

www.thelancet.com

1 1

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Jun 12

👟🎽🚲 16-22 juin : bougez pour le don d’organes !
🫵 Rejoignez la course virtuelle STRAVA : marchez, courez ou pédalez.
🎯 Défi collectif : atteindre 6034 km, nombre de greffes réalisées en France en 2024.
📲 Infos via le QR code, rejoignez-nous vite !
#DéfiDon #DonDorganes #TeamHCL #Greffe #Solidarité🤝!

1 1

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · Jun 11

🚨 Register now for the 2025 International HBV Meeting!

📅Sept. 8-12, 2025 📍Berlin, Germany

➡️ Deadline for abstract submission June 16th.
Early bird registration before July, 18th

🔗 Visit www.hbvmeeting.org for details
@ihuhepatolyon.bsky.social @anrs-mie.bsky.social @easlnews.bsky.social

2 2

Reposted by Armando Andres Roca Suarez

Nature @nature.com · May 31

Researchers with ADHD discuss its peaks and valleys and how they structure their work lives to succeed

https://go.nature.com/3FitQh4

Scientists with ADHD speak up: when fire meets focus

Nature - Researchers with ADHD discuss its peaks and valleys and how they structure their work lives to succeed.

go.nature.com

13 65

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · May 27

🔬🧪 Two open calls at the IHU EVEREST to develop ambitious projects on virology, metabolism, oncology and more!

1) Junior Professor on bioinformatics
📆Deadline: June 30th 2025

2) Group Leader on chronic liver disease
📆Deadline: Sep 1st 2025

ihu-hepatolyon.fr/en/join-us

#Liversky #Medsky #Hepsky

1 2 3

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · May 14

🥁 DEADLINE EXTENDED: June 15!

We are looking for:
✅ 2 research engineers
motivated to work on HBV/HDV biology and antiviral treatments and on the development of innovative 3D ex-vivo cell culture models!

www.ihu-hepatolyon.fr/en/join-us/
#HBV #research #virology #Hepsky #Medsky #Liversky

1 2 2

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Apr 30

📢 We are delighted to announce that Prof. John Tavis 🇺🇲 will be giving an in-person talk in Lyon 🇫🇷
🗓️ Tuesday, May 13, 2025 🕤 9:30 – 10:30 AM

His invited talk, "HBV polymerase: Biochemical engineering and drug discovery", is an open event.

We look forward to welcoming you!

#HBV #hepatology #liver

1 1

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · May 11

The new EASL CPGs on HBV infection have been released yesterday at #EASLCongress What an effort, but what a great journey with an outstanding panel of colleagues! #HBV #Hepatology
@ihuhepatolyon.bsky.social

doi.org/10.1016/j.jh...

2 2 3

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Mar 31

🆕 🔬 🧪 Open call for a Junior Professor Position to develop an ambitious project in #liver #pathobiology on #bioinformatics & #biostatistics that will cover one or more of these topics: #virology, metabolism, #oncology, #immunology etc.

📆 Deadline: 1st June 2025

www.ihu-hepatolyon.fr/en/join-us/

1 2 2

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · Apr 1

🥁 A second call for application is open for MSCA-COFUND International Doctoral Programme ArchiFun.
We have a project linking HBV splicing and liver pathogenesis.
The deadline for application is May 31st 2025.
⬇️ More details here: lnkd.in/d459VH_B
#HBV #liver #PhD @ihuhepatolyon.bsky.social

This link will take you to a page that’s not on LinkedIn

lnkd.in

2 2

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Apr 22

🔙 [ Looking back] on our annual #Hepatology and #Liver Transplantation Days!

📣 We were glad to welcome Catherine Postic as one of our guest speakers.

During her impactful presentation, titled 👉 “Novel insights into glucose and MASLD”, she shared her most recent research.
#MASLD #GlucoseMetabolism

1 1

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Apr 16

💡📅 As World Liver Day approaches on April 19, 2025, our teams are proud to stand alongside the 🌍 global community in raising awareness.

👉 Learn more about our initiatives to preserve, heal, and save livers on our website: www.ihu-hepatolyon.fr/en

#WorldLiverDay #MedicalResearch #HealthAwareness

1 1

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Apr 11

🔝〽️2-day multidisciplinary event on #hepatology and #liver #transplantation!
On April 8–9 2025 in Lyon, we had the pleasure of bringing together our community and a diverse audience to share the latest advances in basic, translational, and #clinical #research in hepatology within our IHU.

1 1

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Apr 15

🔙 on our Hepatology and Liver Transplantation Days!

🤝 We had the pleasure of welcoming @tz-hirsch.bsky.social for a presentation titled: Evolution of Hepatoblastoma: From #Liver Development to Chemoresistance.

🧫 His talk sparked dynamic discussions during the session on #hepatic #pathogenesis.

2 2

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · Mar 21

Great adventure for our #PaThLiv unit members at #GHS2025! Three oral presentations, a poster and always a strong engagement for open science and against viral hepatitis! @ihuhepatolyon.bsky.social #Liversky #HBV #standup4science

1 1

Reposted by Armando Andres Roca Suarez

TestoniResearch @testoniresearch.bsky.social · Mar 21

What’s your job? Is it hard? How do you become a researcher? What skills do you need to begin? Is the salary adequate? 😅 talking with high school students and presenting research and @ihuhepatolyon.bsky.social #womeninSTEM #standup4science

2 4

Reposted by Armando Andres Roca Suarez

Amandine Verga @amandineverga.bsky.social · Mar 11

Présentation sur les nouvelles approches pour guérir l’Hépatite B par Fabien Zoulim de @ihuhepatolyon.bsky.social

Fabien zoulim est sur scène pour faire sa présentation

1 3 4

Reposted by Armando Andres Roca Suarez

ihuhepatolyon.bsky.social @ihuhepatolyon.bsky.social · Feb 28

New dimension in viral hepatitis research

egastroenterology.bmj.com/content/2/3/...

@testoniresearch.bsky.social #liversky #hepsky #medsky

New dimension in viral hepatitis research

Chronic hepatitis B is the leading cause of hepatocellular carcinoma and a significant global health issue, affecting over 296 million people worldwide, with 15 million people coinfected with hepatiti...

egastroenterology.bmj.com

1 6